Global Bioabsorbable Stents Market
Bioabsorbable Stents Market

Report ID: SQMIG35A2995

sales@skyquestt.com
USA +1 351-333-4748

Bioabsorbable Stents Market Size, Share, and Growth Analysis

Global Bioabsorbable Stents Market

Bioabsorbable Stents Market By Product Type (Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents), By Absorption Rate (Slow-Absorption Stents, Fast-Absorption Stents), By Polymer-Based Bioabsorbable Stents, By Metal-Based Bioabsorbable Stents, By Application, By Region - Industry Forecast 2026-2033


Report ID: SQMIG35A2995 | Region: Global | Published Date: February, 2025
Pages: 194 |Tables: 90 |Figures: 71

Format - word format excel data power point presentation

Bioabsorbable Stents Market Insights

Bioabsorbable Stents Market size was valued at USD 2.79 Billion in 2024 and is poised to grow from USD 3.04 Billion in 2025 to USD 6.01 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026–2033).

Several key factors driving the global bioabsorbable stents market growth include the high geriatric population, along with the increasing cases of cardiovascular disease. The growing requirement for treatment in patients suffering from coronary artery disease has resulted in an increased number of PCI procedures, thus higher adoption of bioabsorbable stents among patients and doctors. Further, rapid advancement in stent technology and increasing inclination toward minimally invasive procedures have further increased market growth. The development and production of bioabsorbable stents are being promoted through proactive initiatives from governments across the world, creating a favorable regulatory environment and promoting innovation. Unhealthy dietary habits and a sedentary lifestyle have resulted in increased cardiovascular diseases, thus propelling the need for advanced interventional solutions like bioabsorbable stents.

However, the market has its own set of challenges, such as the high costs of stent procedures and risks associated with bioabsorbable stents. If these challenges are not met with suitable solutions, it could hinder market growth. Contrarily, the growth of the market will be influenced by demographic trends, technological advancement, and government support.

Market snapshot - 2026-2033

Global Market Size

USD 2.56 billion

Largest Segment

Polymer-Based

Fastest Growth

Metallic

Growth Rate

8.9% CAGR

Global Bioabsorbable Stents Market 2026-2033 ($ Bn)
Country Share for North America 2025 (%)

To get more insights on this market click here to Request a Free Sample Report

Bioabsorbable Stents Market Segments Analysis

Global Bioabsorbable Stents Market is segmented by Product Type, Absorption Rate, Polymer-Based Bioabsorbable Stents, Metal-Based Bioabsorbable Stents, Application and region. Based on Product Type, the market is segmented into Polymer-Based Bioabsorbable Stents and Metal-Based Bioabsorbable Stents. Based on Absorption Rate, the market is segmented into Slow-Absorption Stents and Fast-Absorption Stents. Based on Polymer-Based Bioabsorbable Stents, the market is segmented into PLGA (Poly (Lactic-Co-Glycolic Acid)) Stents, PGA (Polyglycolic Acid) Stents, PLLA (Poly (L-Lactic Acid)) Stents and Other Biodegradable Polymer Stents. Based on Metal-Based Bioabsorbable Stents, the market is segmented into Magnesium-Based Stents, Iron-Based Stents, Zinc-Based Stents and Other Metal-Based Bioabsorbable Stents. Based on Application, the market is segmented into Coronary Artery Diseases and Peripheral Artery Diseases. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Analysis by Material Type

As per the 2024 global bioabsorbable stents market analysis, the polymer-based segment dominated the market since these have better biocompatibility and gradual absorption within the body, thus eliminating long-term complications arising from permanent stents. Such advantages include increased flexibility and potential drug elution to prevent restenosis, making the stents more effective for use with coronary artery disease. In addition, with continuous advancements in polymer materials, the mechanical strength and controlled degradation rates are also enhanced, thereby further supporting clinical performance. This is the reason why clinicians are increasingly adopting polymer-based stents, and reliability, safety profile, and post-procedure risks minimization make them the fastest-growing area for adoption among clinicians.

The metallic category is going to grow with innovations in metal alloys and enhancements in engineering during the forecast period. Although polymer-based stents are dominating the market, metallic bioabsorbable stents are picking up rapidly because of superior radial strength and unique controlled degradation properties. Enhancements in surface modification and hybrid stent designs, combining the benefits of both metal and polymer, are further enhancing performance. Increasing clinical evidence of the safety and efficacy of metallic stents in diverse patient populations is driving wider adoption. With ongoing studies to better establish their features, the metallic market is going to experience great strides in the bioabsorbable stent market globally.

Analysis By End User

Based on the 2024 global bioabsorbable stents market forecast, the hospital segment led the market because most stent implantation procedures are done in hospitals. Hospitals are well-equipped with infrastructures, wide types of specialized services, and become the primary point of care for patients requiring any kind of coronary interventions. They provide broad-based diagnostic facilities, interventional cardiology units, and qualified medical teams capable of managing challenging cases in a systematic and effective way. The extensive networks of suppliers in hospitals as well make it easy to accept the new developments in the application of stent therapy. It is from these broad clinical backgrounds and with significant patient turnover that most bioabsorbable stents find application.

The specialized cardiac centers category is predicted to dominate the market in the future as they have focused expertise in cardiovascular care. These centers are heart-related condition-specific and provide advanced facilities designed specifically for advanced cardiac interventions. They can provide tailored treatment options and closely monitor patient outcomes with a concentration of highly skilled cardiologists and specialized interventional teams. Their commitment to the continuous innovation and research needed facilitates early adoption of bioabsorbable stent technologies. Additionally, these centers usually work in concert with academia and industry partners and therefore stay current with related clinical developments and ensure market growth by means of increased procedural success rates.

Global Bioabsorbable Stents Market By Material Type 2026-2033

To get detailed segments analysis, Request a Free Sample Report

Bioabsorbable Stents Market Regional Insights

North America happens to be the most prominent region in the bioabsorbable stents industry due to well-developed health infrastructure, with robust R&D investments and high adoption rates of innovative medical devices. This region is favored by a strong regulatory framework and an extensive presence of specialized cardiovascular treatment centers, which contributes to a huge volume of stent implantation procedures. The region is favored by the U.S. The Food and Drug Administration (FDA), has accelerated the approval and clinical application of bioabsorbable stents. The region also has significant investments in research and development, which continue to propel progress in bioabsorbable stent technology. All these factors have added up to the leadership of North America in market share and sustained influence in determining clinical practices and technological progressions in bioabsorbable stents.

Asia-Pacific is expected to be the fastest-growing region in the bioabsorbable stents market. The main growth drivers in this region are rapidly expanding healthcare infrastructure, rising investments in medical technology, and a growing prevalence of cardiovascular diseases. With improvement in economic conditions, access to advanced treatment options, and supportive government initiatives, the market is currently experiencing further growth. During the forecast period, tremendous growth is going to be witnessed since acceptance of innovative bioabsorbable stent solutions will further grow in the developed healthcare systems of the countries within this region.

Global Bioabsorbable Stents Market By Geography, 2026-2033
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Bioabsorbable Stents Market Dynamics

Bioabsorbable Stents Market Drivers

Advancements in Stent Technology

  • Improved versions of stents in design and technology have hastened the use of coronary artery disease when treated with stents made biodegradable; these stents are made of biodegradable polymers such that after use, the latter degrade naturally. U.S. FDA research found much promise for improving late-stage concerns such as stent thrombosis, which enables better patient improvement and higher levels of adoption through wider markets.

Increasing Healthcare Expenditure and Accessibility

  • Rising investments in healthcare infrastructure and improved accessibility to new medical therapies are the factors driving the global bioabsorbable stent market. According to the World Bank, global health care expenditure has been increasing steadily, and many nations spend more on advanced cardiovascular treatment. In this regard, the rising expenditure on health care, along with the efforts to offer a range of cutting-edge technologies, is boosting the growing demand for bioabsorbable stents as an effective therapy for coronary artery disease.

Bioabsorbable Stents Market Restraints

Clinical Performance Issues

  • Healthcare providers are still wary of the long-term efficacy and safety of bioabsorbable stents. Several first-generation devices have been associated with complications, including late stent thrombosis and restenosis, which have raised concerns over their clinical performance. These adverse outcomes have dampened market confidence, prompting clinicians to call for more robust clinical trials and improved device designs. Enhanced safety profiles and long-term data are needed to restore trust in bioabsorbable stent technology.

High Production Costs

  • The manufacture of biodegradable stents is highly sophisticated and requires specialty material manufacturing. Complexity and costs of production are intrinsic and several folds higher as against a conventional metallic stent. Such enhanced costs pass through to the service providers and patients, which limits their affordability and access, particularly in cost-sensitive markets. Thus, the high cost of production remains a significant barrier to mass-market penetration and overall growth for this technology.

Request Free Customization of this report to help us to meet your business objectives.

Bioabsorbable Stents Market Competitive Landscape

The global bioabsorbable stents market is highly competitive, partly due to significant investments in research and development and technological innovation. Abbott Laboratories, Boston Scientific, and Medtronic are among the foremost organizations that are optimizing device performance by means of strategic partnerships and advanced clinical trials. By emphasizing enhanced efficacy and safety, emerging actors are acquiring market share. Manufacturers are pursuing regulatory approvals, cost cutting, and global expansion in a diverse range of strong international markets, and as a result, competition overall is increased.

Top Player’s Company Profile

  • Boston Scientific Corporation (USA)
  • Arterius Limited (UK) 
  • Kyoto Medical Planning Co., Ltd. (Japan) 
  • Terumo Corporation (Japan) 
  • Elixir Medical Corporation (USA) 
  • Abbott Laboratories Inc. (USA) 
  • Amaranth Medical (USA) 
  • Biotronik (Germany) 
  • Meril Life Sciences Pvt. Ltd. (India) 
  • Reva Medical (USA) 
  • Svelte Medical Systems (USA) 
  • Lepu Medical Technology Co., Ltd. (China) 
  • Medtronic plc (Ireland) 
  • B. Braun Melsungen AG (Germany) 
  • MicroPort Scientific Corporation (China) 
  • Cardionovum GmbH (Germany) 
  • Biotronik SE & Co. KG (Germany) 
  • ICON Interventional Systems (USA) 
  • Arterial Remodeling Technologies (France) 
  • Elixir Medical Corporation (USA)

Recent Developments

  • Abbott gained FDA approval for its next-generation bioabsorbable stent in June 2023, with improved polymer materials to better treat coronary artery disease in patients. This stent has enhanced radial strength and a more predictable degradation profile, which is a significant advancement in bioabsorbable stent technology.
  • Biotronik launched the Magmaris Resorbable Magnesium Scaffold in several European countries starting April 2023. The magnesium scaffold is a stent made of magnesium alloy that provides temporary support to blood vessels but is entirely absorbed by the body with few long-term complications associated with metal stents.
  • Medtronic Plc unveiled the Absorb Bioresorbable Vascular Scaffold (BVS) for treating coronary artery disease in some global markets in February 2023. This new development was going to assist patients because it is supposed to break down gradually in the body, giving patients a chance other than having permanent metallic stents. The Absorb BVS is designed to eliminate complications such as restenosis in the treatment of coronary artery disease with bioabsorbable solutions.

Bioabsorbable Stents Key Market Trends

Bioabsorbable Stents Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, the global bioabsorbable stents market outlook will witness a lot of potential, and this growth is primarily being fueled by the rising incidence of cardiovascular diseases, advancements in material science, and preference for minimal invasiveness. The polymer-based stents rule the market due to greater biocompatibility and controlled absorption. The metallic group is expected to grow at a rapid rate. Currently, the hospital segment is driving the market. In the future, though, the specialist cardiac centers will take precedence over it. There are a number of issues and challenges such as high production cost and clinical performance which need to be addressed to ensure proper improvement in drug eluting capabilities and new materials. It is going to be on an increasing phase because it has provided the facility for advanced treatments for coronary artery diseases.

Report Metric Details
Market size value in 2024 USD 2.79 Billion
Market size value in 2033 USD 6.01 Billion
Growth Rate 8.9%
Base year 2024
Forecast period 2026-2033
Forecast Unit (Value) USD Billion
Segments covered
  • Material Type
    • Polymer-Based, Metallic, and Others
  • Application
    • Coronary, Peripheral, and Others
  • End User
    • Hospitals, Specialized Cardiac Centers, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Boston Scientific Corporation (USA)
  • Arterius Limited (UK) 
  • Kyoto Medical Planning Co., Ltd. (Japan) 
  • Terumo Corporation (Japan) 
  • Elixir Medical Corporation (USA) 
  • Abbott Laboratories Inc. (USA) 
  • Amaranth Medical (USA) 
  • Biotronik (Germany) 
  • Meril Life Sciences Pvt. Ltd. (India) 
  • Reva Medical (USA) 
  • Svelte Medical Systems (USA) 
  • Lepu Medical Technology Co., Ltd. (China) 
  • Medtronic plc (Ireland) 
  • B. Braun Melsungen AG (Germany) 
  • MicroPort Scientific Corporation (China) 
  • Cardionovum GmbH (Germany) 
  • Biotronik SE & Co. KG (Germany) 
  • ICON Interventional Systems (USA) 
  • Arterial Remodeling Technologies (France) 
  • Elixir Medical Corporation (USA)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Bioabsorbable Stents Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Bioabsorbable Stents Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Bioabsorbable Stents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Bioabsorbable Stents Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Bioabsorbable Stents Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Bioabsorbable Stents Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

Bioabsorbable Stents Market Report Snapshots

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Bioabsorbable Stents Market size was valued at USD 2.79 Billion in 2024 and is poised to grow from USD 3.04 Billion in 2025 to USD 6.01 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026–2033).

The global bioabsorbable stents market is highly competitive, partly due to significant investments in research and development and technological innovation. Abbott Laboratories, Boston Scientific, and Medtronic are among the foremost organizations that are optimizing device performance by means of strategic partnerships and advanced clinical trials. By emphasizing enhanced efficacy and safety, emerging actors are acquiring market share. Manufacturers are pursuing regulatory approvals, cost cutting, and global expansion in a diverse range of strong international markets, and as a result, competition overall is increased. 'Boston Scientific Corporation (USA)', 'Arterius Limited (UK) ', 'Kyoto Medical Planning Co., Ltd. (Japan) ', 'Terumo Corporation (Japan) ', 'Elixir Medical Corporation (USA) ', 'Abbott Laboratories Inc. (USA) ', 'Amaranth Medical (USA) ', 'Biotronik (Germany) ', 'Meril Life Sciences Pvt. Ltd. (India) ', 'Reva Medical (USA) ', 'Svelte Medical Systems (USA) ', 'Lepu Medical Technology Co., Ltd. (China) ', 'Medtronic plc (Ireland) ', 'B. Braun Melsungen AG (Germany) ', 'MicroPort Scientific Corporation (China) ', 'Cardionovum GmbH (Germany) ', 'Biotronik SE & Co. KG (Germany) ', 'ICON Interventional Systems (USA) ', 'Arterial Remodeling Technologies (France) ', 'Elixir Medical Corporation (USA)'

Improved versions of stents in design and technology have hastened the use of coronary artery disease when treated with stents made biodegradable; these stents are made of biodegradable polymers such that after use, the latter degrade naturally. U.S. FDA research found much promise for improving late-stage concerns such as stent thrombosis, which enables better patient improvement and higher levels of adoption through wider markets.

Concentrate on the Development of New Materials: The current research in the global bioabsorbable stent market is concentrated on the development of new materials that offer improved biocompatibility, enhanced mechanical strength, and controlled degradation rates. Researchers are investigating composite materials that integrate the advantages of both metals and polymers to enhance patient outcomes, durability, and performance. The objective of these advancements is to circumvent the constraints of current materials, thereby enhancing the long-term efficacy of bioabsorbable stents and minimizing complications.

North America happens to be the most prominent region in the bioabsorbable stents industry due to well-developed health infrastructure, with robust R&D investments and high adoption rates of innovative medical devices. This region is favored by a strong regulatory framework and an extensive presence of specialized cardiovascular treatment centers, which contributes to a huge volume of stent implantation procedures. The region is favored by the U.S. The Food and Drug Administration (FDA), has accelerated the approval and clinical application of bioabsorbable stents. The region also has significant investments in research and development, which continue to propel progress in bioabsorbable stent technology. All these factors have added up to the leadership of North America in market share and sustained influence in determining clinical practices and technological progressions in bioabsorbable stents.
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients